Ryousuke Satou

Dr. Ryousuke Satou

Department of Physiology and Hypertension and Renal Center of Excellence, Tulane University School of Medicine, New Orleans, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2018 in Current Hypertension Reports
Verified
Journal Article
Closed access
PDF file
RSRyousuke Satou
Ryousuke Satou
HPHarrison Penrose
Harrison Penrose
LNL. Gabriel Navar
L. Gabriel Navar

11 January 2019 in Biology of Sex Differences
Verified
Journal Article
Open access
PDF file
DHDillion Hutson
Dillion Hutson
RGRakesh Gurrala
Rakesh Gurrala
BOBenard O. Ogola
Benard O. Ogola
MZMargaret Zimmerman
Margaret Zimmerman
RMRicardo Mostany
Ricardo Mostany
SLSarah Lindsey
Sarah Lindsey
Estrogen is formed by the enzyme aromatase (CYP19A1) and signals via three identified receptors ERα (ESR1), ERß (ESR2), and the G protein-coupled estrogen receptor (GPER). Understanding the relative contribution of each receptor to estrogenic signaling may elucidate the disparate effects of this sex hormone across tissues, and recent developments in PCR technology allow absolute quantification and direct comparison of multiple targets. We hypothesized that this approach would reveal tissue- and sex-specific differences in estrogen receptor mRNA. ESR1, ESR2, GPER, and CYP19A1 were measured in four cardiovascular tissues (heart, aorta, kidney, and adrenal gland), three brain areas (somatosensory cortex, hippocampus, and prefrontal cortex), and reproductive tissues (ovaries, mammary gland, uterus, testes) from six male and six female adult Sprague-Dawley rats. GPER mRNA expression was relatively stable across all tissues in both sexes, ranging from 5.49 to 113 copies/ng RNA, a 21-fold difference. In contrast, ESR1/ESR2 were variable across tissues although similar within an organ system. ESR1 ranged from 4.46 to 614 copies/ng RNA (138-fold difference) while ESR2 ranged from 0.154 to 83.1 copies/ng RNA (540-fold). Significant sex differences were broadly absent except for renal ESR1 (female 206 vs. male 614 copies/ng RNA, P < 0.0001) and GPER (62.0 vs. 30.2 copies/ng RNA, P < 0.05) as well as gonadal GPER (5.49 vs. 47.5 copies/ng RNA, P < 0.01), ESR2 (83.1 vs. 0.299 copies/ng RNA, P < 0.01), and CYP19A1 (322 vs. 7.18 copies/ng RNA, P < 0.01). Cardiovascular tissues showed a predominance of ESR1, followed by GPER. In contrast, GPER was the predominant transcript in the brain with similarly low levels of ESR1 and ESR2. CYP19A1 was detected at very low levels except for reproductive tissues and the hippocampus. While the data indicates a lack of sex differences in most tissues, significant differences were found in the range of receptor gene expression across tissues as well as in the receptor profile between organ systems. The data provide a guide for future studies by establishing estrogen receptor expression across multiple tissues using absolute PCR quantification. This knowledge on tissue-specific estrogen receptor profiles will aid the development of hormonal therapies that elicit beneficial effects in specific tissues.

1 February 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
RSRyousuke Satou
Ryousuke Satou
KMKayoko Miyata
Kayoko Miyata
RGRomer A. Gonzalez‐Villalobos
Romer A. Gonzalez‐Villalobos
JIJulie R. Ingelfinger
Julie R. Ingelfinger
LNL. Gabriel Navar
L. Gabriel Navar
HKHiroyuki Kobori
Hiroyuki Kobori
Renal inflammation modulates angiotensinogen (AGT) production in renal proximal tubular cells (RPTCs) via inflammatory cytokines, including interleukin‐6, tumor necrosis factor α, and interferon‐γ (IFN‐γ). Among these, the effects of IFN‐γ on AGT regulation in RPTCs are incompletely delineated. This study aimed to elucidate mechanisms by which IFN‐γ regulates AGT expression in RPTCs. RPTCs were incubated with or without IFN‐γ up to 48 h. AGT expression, STAT1 and STAT3 activities, and SOCS1 expression were evaluated. RNA interference studies against STAT1, SOCS1, and STAT3 were performed to elucidate a signaling cascade. IFN‐γ decreased AGT expression at 6 h (0.61 ±0.05, ratio to control) and 12 h (0.47±0.03). In contrast, longer exposure for 24 and 48 h increased AGT expression (1.76±0.18, EC 50 = 3.4 ng/ml, and 1.45±0.08, respectively). IFN‐γ treatment for 6 h strongly induced STAT1 phosphorylation and SOCS1 augmentation, and decreased STAT3 activity. However, STAT1 phosphorylation and SOCS1 augmentation waned at 24 h, while STAT3 activity increased. RNA interference studies revealed that activation of STAT1‐SOCS1 axis decreased STAT3 activity. Thus, IFN‐γ biphasically regulates AGT expression in RPTCs via STAT3 activity modulated by STAT1‐SOCS1 axis, suggesting the STAT1‐SOCS1 axis is important in IFN‐γ‐induced activation of the intrarenal renin‐angiotensin system.—Satou, R., Miyata, K., Gonzalez‐Villalobos, R. A., Ingelfinger, J. R., Navar, L. G., Kobori, H. Interferon‐γ biphasically regulates angiotensinogen expression via a JAK‐STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells. FASEB J. 26, 1821‐1830 (2012). www.fasebj.org

20 October 2012 in JAK-STAT
Verified
Journal Article
Open access
RSRyousuke Satou
Ryousuke Satou
RGRomer A. Gonzalez-Villalobos
Romer A. Gonzalez-Villalobos
The renin-angiotensin system (RAS) plays important roles in blood pressure control and tissue disease. An inappropriate local angiotensin II elevation in the kidneys leads to the development of hyp...

1 January 2020 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
RSRyousuke Satou
Ryousuke Satou
MCMichael W. Cypress
Michael W. Cypress
TWT. Cooper Woods
T. Cooper Woods
AKAkemi Katsurada
Akemi Katsurada
CDCourtney M. Dugas
Courtney M. Dugas
Luis Gabriel NavarLuis Gabriel Navar
Luis Gabriel Navar
Renal proximal tubular angiotensinogen (AGT) is increased by hyperglycemia (HG) in diabetes mellitus, which augments intrarenal angiotensin II formation, contributing to the development of hypertension and kidney injury. Sodium-glucose cotransporter 2 (SGLT2) is abundantly expressed in proximal tubular cells (PTCs). The present study investigated the effects of canagliflozin (CANA), a SGLT2 inhibitor, on HG-induced AGT elevation in cultured PTCs. Mouse PTCs were treated with 5–25 mM glucose. CANA (0–10 µM) was applied 1 h before glucose treatment. Glucose (10 mM) increased AGT mRNA and protein levels at 12 h (3.06 ± 0.48-fold in protein), and 1 and 10 µM CANA as well as SGLT2 shRNA attenuated the AGT augmentation. CANA did not suppress the elevated AGT levels induced by 25 mM glucose. Increased AGT expression induced by treatment with pyruvate, a glucose metabolite that does not require SGLT2 for uptake, was not attenuated by CANA. In HG-treated PTCs, intracellular reactive oxygen species levels were elevated compared with baseline (4.24 ± 0.23-fold), and these were also inhibited by CANA. Furthermore, tempol, an antioxidant, attenuated AGT upregulation in HG-treated PTCs. HG-induced AGT upregulation was not inhibited by an angiotensin II receptor antagonist, indicating that HG stimulates AGT expression in an angiotensin II-independent manner. These results indicate that enhanced glucose entry via SGLT2 into PTCs elevates intracellular reactive oxygen species generation by stimulation of glycolysis and consequent AGT augmentation. SGLT2 blockade limits HG-induced AGT stimulation, thus reducing the development of kidney injury in diabetes mellitus.

15 May 2016 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Open access
PDF file
RORyan O'LEary
Ryan O'LEary
HPHarrison Penrose
Harrison Penrose
KMKayoko Miyata
Kayoko Miyata
RSRyousuke Satou
Ryousuke Satou
The development of ANG II-dependent hypertension involves increased infiltration of macrophages (MΦ) and T cells into the kidney and the consequent elevation of intrarenal cytokines including IL-6, which facilitates the progression of hypertension and associated kidney injury. Intrarenal renin-angiotensin system (RAS) activation, including proximal tubular angiotensinogen (AGT) stimulation, has also been regarded as a cardinal mechanism contributing to these diseases. However, the interaction between immune cells and intrarenal RAS activation has not been fully delineated. Therefore, the present study investigated whether ANG II-treated MΦ induce AGT upregulation in renal proximal tubular cells (PTCs). MΦ were treated with 0–10−6M ANG II for up to 48 h. PTCs were incubated with the collected medium from MΦ. In ANG II-treated MΦ, IL-6 mRNA and protein levels were increased (1.86 ± 0.14, protein level, ratio to control); moreover, IL-6 levels were higher than TNF-α and IL-1β in culture medium isolated from ANG II-treated MΦ. Elevated AGT expression (1.69 ± 0.04, ratio to control) accompanied by phosphorylated STAT3 were observed in PTCs that received culture medium from ANG II-treated MΦ. The addition of a neutralizing IL-6 antibody to the collected medium attenuated phosphorylation of STAT3 and AGT augmentation in PTCs. Furthermore, a JAK2 inhibitor also suppressed STAT3 phosphorylation and AGT augmentation in PTCs. These results demonstrate that ANG II-induced IL-6 elevation in MΦ enhances activation of the JAK-STAT pathway and consequent AGT upregulation in PTCs, suggesting involvement of an immune response in driving intrarenal RAS activity.